Home / Latest Reports / Plantar Fasciitis Treatment Market

Plantar Fasciitis Treatment Market by Type and End User - Global Industry Analysis & Forecast to 2027

Published On : August 2019 Pages : 172 Category: Pharma & Healthcare Report Code : HC084986

SEGMENTS & REGIONS:

  • Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa

Plantar Fasciitis Treatment Market by Type (Orthotics, Shockwave Therapy, Medication Therapy, Surgery) End User (Clinics, Hospitals) - Global Industry Analysis & Forecast to 2027

Industry Outlook and Trend Analysis

The plantar fasciitis treatment market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Plantar fasciitis is caused by repetitive strain injury and it is common cause of foot pain. Strain injury causing small scale tears the tendon as it connects to the impact point bone or different territories of snugness on the underside of the foot. Plantar fasciitis causes mainly foot arch pain or heel pain, and morning foot pain. Foot stretches and activities can help plantar fasciitis by calming torment, improving muscle quality, and advancing adaptability in the foot muscles and tendons.

Drivers and Restraints

Growing adoption of technologically advanced products drives the growth of plantar fasciitis treatment market. These products help plantar fasciitis by calming torment. Inactive lifestyle can increase the risk of plantar fasciitis as well as changing preference of individuals regarding eating coupled with increasing cases of plantar fasciitis. Furthermore, rise I the number of treatments propels the growth of plantar fasciitis treatment market. Increasing geriatric population fuels the growth of plantar fasciitis treatment market. However, unstable pricing of raw materials may hamper the growth of plantar fasciitis treatment market.

Regional Insights

Among the geographies, North America is expected to dominate the plantar fasciitis treatment market. High adoption of advanced treatment approaches in the region contribute to the growth of plantar fasciitis treatment market.

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Southeast Asia
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Columbia
    • Rest of South America
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Nigeria
    • South Africa
    • Rest of MEA

Competitive Analysis                         

The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

  • GlaxoSmithKline plc
  • Sanofi
  • Pfizer, Inc.
  • Ottobock SE & Co. KGaA
  • Superfeet Worldwide, Inc.
  • Bauerfeind AG
  • A. Algeo Limited
  • Bayer Group
  • Hanger, Inc.

Some of the key questions answered by the report are:

  • What was the market size in 2017 and forecast from 2017 to 2027?
  • What will be the industry market growth from 2017 to 2027?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

o   Plantar Fasciitis Treatment Market, By Type, Estimates and Forecast, 2017-2027 ($Million)

o   Orthotics

o   Shockwave Therapy

o   Medication Therapy

o   Surgery

o   Plantar Fasciitis Treatment Market, By End User, Estimates and Forecast, 2017-2027 ($Million)

o   Clinics

o   Hospitals

o   Plantar Fasciitis Treatment Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)

o   GlaxoSmithKline plc

o   Sanofi

o   Pfizer, Inc.

o   Ottobock SE & Co. KGaA

o   Superfeet Worldwide, Inc.

o   Bauerfeind AG

o   A. Algeo Limited

o   Bayer Group

o   Hanger, Inc.

o   Plantar Fasciitis Treatment Market, By Region, Estimates and Forecast, 2017-2027 ($Million)

o   North America

§  North America Plantar Fasciitis Treatment Market , By Country

o   U.S. Plantar Fasciitis Treatment Market

o   Canada Plantar Fasciitis Treatment Market

o   Mexico Plantar Fasciitis Treatment Market

o   Europe

§  Europe Plantar Fasciitis Treatment Market , By Country

o   Germany Plantar Fasciitis Treatment Market

o   UK Plantar Fasciitis Treatment Market

o   France Plantar Fasciitis Treatment Market

o   Russia Plantar Fasciitis Treatment Market

o   Italy Plantar Fasciitis Treatment Market

o   Rest of Europe Plantar Fasciitis Treatment Market

o   Asia-Pacific

§  Asia-Pacific Plantar Fasciitis Treatment Market , By Country

o   China Plantar Fasciitis Treatment Market

o   Japan Plantar Fasciitis Treatment Market

o   South Korea  Plantar Fasciitis Treatment Market

o   India Plantar Fasciitis Treatment Market

o   Southeast Asia Plantar Fasciitis Treatment Market

o   Rest of Asia-Pacific Plantar Fasciitis Treatment Market

o   South America

§  South America Plantar Fasciitis Treatment Market , By Country

o   Brazil Plantar Fasciitis Treatment Market

o   Argentina Plantar Fasciitis Treatment Market

o   Columbia Plantar Fasciitis Treatment Market

o   Rest of South America Plantar Fasciitis Treatment Market

o   Middle East and Africa

§  Middle East and Africa Plantar Fasciitis Treatment Market , By Country

o   Saudi Arabia Plantar Fasciitis Treatment Market

o   UAE Plantar Fasciitis Treatment Market

o   Egypt Plantar Fasciitis Treatment Market

o   Nigeria Plantar Fasciitis Treatment Market

o   South Africa Plantar Fasciitis Treatment Market

o   Rest of MEA Plantar Fasciitis Treatment Market

Table of Contents:

1.       Introduction

1.1.     Report Description

2.       Executive Summary

2.1.     Key Highlights

3.       Market Overview

3.1.     Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.     Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

4.       Market Analysis by Regions

4.1.     North America (United States, Canada and Mexico)

4.1.1.  United States Market Status and Outlook (2017-2027)

4.1.2.  Canada Market Status and Outlook (2017-2027)

4.1.3.  Mexico Market Status and Outlook (2017-2027)

4.2.     Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market Status and Outlook (2017-2027)

4.2.2.  France Market Status and Outlook (2017-2027)

4.2.3.  UK Market Status and Outlook (2017-2027)

4.2.4.  Russia Market Status and Outlook (2017-2027)

4.2.5.  Italy Market Status and Outlook (2017-2027)

4.2.6.  Rest of Europe Market Status and Outlook (2017-2027)

4.3.     Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market Status and Outlook (2017-2027)

4.3.2.  Japan Market Status and Outlook (2017-2027)

4.3.3.  Korea Market Status and Outlook (2017-2027)

4.3.4.  India Market Status and Outlook (2017-2027)

4.3.5.  Southeast Asia Market Status and Outlook (2017-2027)

4.3.6.  Rest of Asia-Pacific Market Status and Outlook (2017-2027)

4.4.     South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market Status and Outlook (2017-2027)

4.4.2.  Argentina Market Status and Outlook (2017-2027)

4.4.3.  Columbia Market Status and Outlook (2017-2027)

4.4.4.  Rest of South America Market Status and Outlook (2017-2027)

4.5.     Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market Status and Outlook (2017-2027)

4.5.2.  United Arab Emirates Market Status and Outlook (2017-2027)

4.5.3.  Egypt Market Status and Outlook (2017-2027)

4.5.4.  Nigeria Market Status and Outlook (2017-2027)

4.5.5.  South Africa Market Status and Outlook (2017-2027)

4.5.6.  Turkey Market Status and Outlook (2017-2027)

4.5.7.  Rest of Middle East and Africa Market Status and Outlook (2017-2027)

5.       Plantar Fasciitis Treatment Market, By Type

5.1.     Introduction

5.2.     Global Plantar Fasciitis Treatment Revenue and Market Share by Type (2017-2027)

5.2.1.  Global Plantar Fasciitis Treatment Revenue and Revenue Share by Type (2017-2027)

5.3.     Orthotics

5.3.1.  Global Orthotics Revenue and Growth Rate (2017-2027)

5.4.     Shockwave Therapy

5.4.1.  Global Shockwave Therapy Revenue and Growth Rate (2017-2027)

5.5.     Medication Therapy

5.5.1.  Global Medication Therapy Revenue and Growth Rate (2017-2027)

5.6.     Surgery

5.6.1.  Global Surgery Revenue and Growth Rate (2017-2027)

6.       Plantar Fasciitis Treatment Market, By End User

6.1.     Introduction

6.2.     Global Plantar Fasciitis Treatment Revenue and Market Share by End User (2017-2027)

6.2.1.  Global Plantar Fasciitis Treatment Revenue and Revenue Share by End User (2017-2027)

6.3.     Clinics

6.3.1.  Global Clinics Revenue and Growth Rate (2017-2027)

6.4.     Hospitals

6.4.1.  Global Hospitals Revenue and Growth Rate (2017-2027)

7.       Plantar Fasciitis Treatment Market, By Region

7.1.     Introduction

7.2.     Global Plantar Fasciitis Treatment Revenue and Market Share by Regions

7.2.1.  Global Plantar Fasciitis Treatment Revenue by Regions (2017-2027)

7.3.     North America Plantar Fasciitis Treatment by Countries

7.3.1.  North America Plantar Fasciitis Treatment Revenue and Growth Rate (2017-2027)

7.3.2.  North America Plantar Fasciitis Treatment Revenue (Million USD) by Countries (2017-2027)

7.3.3.  United States

7.3.3.1.  United States Plantar Fasciitis Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

7.3.4.  Canada

7.3.4.1.  Canada Plantar Fasciitis Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

7.3.5.  Mexico

7.3.5.1.  Mexico Plantar Fasciitis Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.     Europe Plantar Fasciitis Treatment by Countries

7.4.1.  Europe Plantar Fasciitis Treatment Revenue and Growth Rate (2017-2027)

7.4.2.  Europe Plantar Fasciitis Treatment Revenue (Million USD) by Countries (2017-2027)

7.4.3.  Germany

7.4.3.1.  Germany Plantar Fasciitis Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.4.  France

7.4.4.1.  France Plantar Fasciitis Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.5.  UK

7.4.5.1.  UK Plantar Fasciitis Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.6.  Russia

7.4.6.1.  Russia Plantar Fasciitis Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.7.  Italy

7.4.7.1.  Italy Plantar Fasciitis Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.8.  Rest of Europe

7.4.8.1.  Rest of Europe Plantar Fasciitis Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.     Asia-Pacific Plantar Fasciitis Treatment by Countries

7.5.1.  Asia-Pacific Plantar Fasciitis Treatment Revenue and Growth Rate (2017-2027)

7.5.2.  Asia-Pacific Plantar Fasciitis Treatment Revenue (Million USD) by Countries (2017-2027)

7.5.3.  China

7.5.3.1.  China Plantar Fasciitis Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.4.  Japan

7.5.4.1.  Japan Plantar Fasciitis Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.5.  Korea

7.5.5.1.  Korea Plantar Fasciitis Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.6.  India

7.5.6.1.  India Plantar Fasciitis Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.7.  Southeast Asia

7.5.7.1.  Southeast Asia Plantar Fasciitis Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.8.  Rest of Asia-Pacific

7.5.8.1.  Rest of Asia-Pacific Plantar Fasciitis Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.     South America Plantar Fasciitis Treatment by Countries

7.6.1.  South America Plantar Fasciitis Treatment Revenue and Growth Rate (2017-2027)

7.6.2.  South America Plantar Fasciitis Treatment Revenue (Million USD) by Countries (2017-2027)

7.6.3.  Brazil

7.6.3.1.  Brazil Plantar Fasciitis Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.4.  Argentina

7.6.4.1.  Argentina Plantar Fasciitis Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.5.  Columbia

7.6.5.1.  Columbia Plantar Fasciitis Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.6.  Rest of South America

7.6.6.1.  Rest of South America Plantar Fasciitis Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.     Middle East and Africa Plantar Fasciitis Treatment by Countries

7.7.1.  Middle East and Africa Plantar Fasciitis Treatment Revenue and Growth Rate (2017-2027)

7.7.2.  Middle East and Africa Plantar Fasciitis Treatment Revenue (Million USD) by Countries (2017-2027)

7.7.3.  Saudi Arabia

7.7.3.1.  Saudi Arabia Plantar Fasciitis Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.4.  United Arab Emirates

7.7.4.1.  United Arab Emirates Plantar Fasciitis Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.5.  Egypt

7.7.5.1.  Egypt Plantar Fasciitis Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.6.  Nigeria

7.7.6.1.  Nigeria Plantar Fasciitis Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.7.  South Africa

7.7.7.1.  South Africa Plantar Fasciitis Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.8.  Turkey

7.7.8.1.  Turkey Plantar Fasciitis Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.9.  Rest of Middle East and Africa

7.7.9.1.  Rest of Middle East and Africa Plantar Fasciitis Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

8.       Company Profiles

8.1.     GlaxoSmithKline plc

8.1.1.  Business Overview

8.1.2.   Service Portfolio

8.1.3.  Strategic Developments

8.1.4.  Financial Overview

8.2.     Sanofi

8.2.1.  Business Overview

8.2.2.   Service Portfolio

8.2.3.  Strategic Developments

8.2.4.  Financial Overview

8.3.     Pfizer, Inc.

8.3.1.  Business Overview

8.3.2.   Service Portfolio

8.3.3.  Strategic Developments

8.3.4.  Financial Overview

8.4.     Ottobock SE & Co. KGaA

8.4.1.  Business Overview

8.4.2.   Service Portfolio

8.4.3.  Strategic Developments

8.4.4.  Financial Overview

8.5.     Superfeet Worldwide, Inc.

8.5.1.  Business Overview

8.5.2.   Service Portfolio

8.5.3.  Strategic Developments

8.5.4.  Financial Overview

8.6.     Bauerfeind AG

8.6.1.  Business Overview

8.6.2.   Service Portfolio

8.6.3.  Strategic Developments

8.6.4.  Financial Overview

8.7.     A. Algeo Limited

8.7.1.  Business Overview

8.7.2.   Service Portfolio

8.7.3.  Strategic Developments

8.7.4.  Financial Overview

8.8.     Bayer Group

8.8.1.  Business Overview

8.8.2.   Service Portfolio

8.8.3.  Strategic Developments

8.8.4.  Financial Overview

8.9.     Hanger, Inc.

8.9.1.  Business Overview

8.9.2.   Service Portfolio

8.9.3.  Strategic Developments

8.9.4.  Financial Overview

9.       Plantar Fasciitis Treatment Market Forecast (2017-2027)

9.1.     Global Plantar Fasciitis Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

9.2.     Plantar Fasciitis Treatment Market Forecast by Regions (2017-2027)

9.2.1.  North America Plantar Fasciitis Treatment Market Forecast (2017-2027)

9.2.1.1.  United States Plantar Fasciitis Treatment Market Forecast (2017-2027)

9.2.1.2.  Canada Plantar Fasciitis Treatment Market Forecast (2017-2027)

9.2.1.3.  Mexico Plantar Fasciitis Treatment Market Forecast (2017-2027)

9.2.2.  Europe Plantar Fasciitis Treatment Market Forecast (2017-2027)

9.2.2.1.  Germany Plantar Fasciitis Treatment Market Forecast (2017-2027)

9.2.2.2.  France Plantar Fasciitis Treatment Market Forecast (2017-2027)

9.2.2.3.  UK Plantar Fasciitis Treatment Market Forecast (2017-2027)

9.2.2.4.  Russia Plantar Fasciitis Treatment Market Forecast (2017-2027)

9.2.2.5.  Italy Plantar Fasciitis Treatment Market Forecast (2017-2027)

9.2.2.6.  Rest of Europe Plantar Fasciitis Treatment Market Forecast (2017-2027)

9.2.3.  Asia-Pacific Plantar Fasciitis Treatment Market Forecast (2017-2027)

9.2.3.1.  China Plantar Fasciitis Treatment Market Forecast (2017-2027)

9.2.3.2.  Japan Plantar Fasciitis Treatment Market Forecast (2017-2027)

9.2.3.3.  Korea Plantar Fasciitis Treatment Market Forecast (2017-2027)

9.2.3.4.  India Plantar Fasciitis Treatment Market Forecast (2017-2027)

9.2.3.5.  Southeast Asia Plantar Fasciitis Treatment Market Forecast (2017-2027)

9.2.3.6.  Rest of Asia-Pacific Plantar Fasciitis Treatment Market Forecast (2017-2027)

9.2.4.  South America Plantar Fasciitis Treatment Market Forecast (2017-2027)

9.2.4.1.  Brazil Plantar Fasciitis Treatment Market Forecast (2017-2027)

9.2.4.2.  Argentina Plantar Fasciitis Treatment Market Forecast (2017-2027)

9.2.4.3.  Columbia Plantar Fasciitis Treatment Market Forecast (2017-2027)

9.2.4.4.  Rest of South America Plantar Fasciitis Treatment Market Forecast (2017-2027)

9.2.5.  Middle East and Africa Plantar Fasciitis Treatment Market Forecast (2017-2027)

9.2.5.1.  Saudi Arabia Plantar Fasciitis Treatment Market Forecast (2017-2027)

9.2.5.2.  United Arab Emirates Plantar Fasciitis Treatment Market Forecast (2017-2027)

9.2.5.3.  Egypt Plantar Fasciitis Treatment Market Forecast (2017-2027)

9.2.5.4.  Nigeria Plantar Fasciitis Treatment Market Forecast (2017-2027)

9.2.5.5.  South Africa Plantar Fasciitis Treatment Market Forecast (2017-2027)

9.2.5.6.  Turkey Plantar Fasciitis Treatment Market Forecast (2017-2027)

9.2.5.7.  Rest of Middle East and Africa Plantar Fasciitis Treatment Market Forecast (2017-2027)

9.3.     Plantar Fasciitis Treatment Market Forecast by Type (2017-2027)

9.3.1.  Plantar Fasciitis Treatment Forecast by Type (2017-2027)

9.3.2.  Plantar Fasciitis Treatment Market Share Forecast by Type (2017-2027)

9.4.     Plantar Fasciitis Treatment Market Forecast by End User (2017-2027)

9.4.1.  Plantar Fasciitis Treatment Forecast by End User (2017-2027)

9.4.2.  Plantar Fasciitis Treatment Market Share Forecast by End User (2017-2027)

List of Tables

List of Tables and Figures:

Figure United States Plantar Fasciitis Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Plantar Fasciitis Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Plantar Fasciitis Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Plantar Fasciitis Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Plantar Fasciitis Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Plantar Fasciitis Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Plantar Fasciitis Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Plantar Fasciitis Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Plantar Fasciitis Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Plantar Fasciitis Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Plantar Fasciitis Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Plantar Fasciitis Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Plantar Fasciitis Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Plantar Fasciitis Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Plantar Fasciitis Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Plantar Fasciitis Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Plantar Fasciitis Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Plantar Fasciitis Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Plantar Fasciitis Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Plantar Fasciitis Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Plantar Fasciitis Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Plantar Fasciitis Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Plantar Fasciitis Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Plantar Fasciitis Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Plantar Fasciitis Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Plantar Fasciitis Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Plantar Fasciitis Treatment Revenue and Revenue Share by Type (2017-2018)
Figure Global Orthotics Revenue and Growth Rate (2017-2018)
Figure Global Shockwave Therapy Revenue and Growth Rate (2017-2018)
Figure Global Medication Therapy Revenue and Growth Rate (2017-2018)
Figure Global Surgery Revenue and Growth Rate (2017-2018)
Table Global Plantar Fasciitis Treatment Revenue and Revenue Share by End User (2017-2018)
Figure Global Clinics Revenue and Growth Rate (2017-2018)
Figure Global Hospitals Revenue and Growth Rate (2017-2018)
Table Global Plantar Fasciitis Treatment Revenue by Regions (2017-2018)
Figure North America Plantar Fasciitis Treatment Growth Rate (2017-2018)
Figure North America Plantar Fasciitis Treatment Revenue and Growth Rate (2017-2018)
Figure North America Plantar Fasciitis Treatment by Countries (2017-2018)
Figure North America Plantar Fasciitis Treatment Revenue (Million USD) by Countries (2017-2018)
Figure United States Plantar Fasciitis Treatment Growth Rate (2017-2018)
Figure United States Plantar Fasciitis Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Plantar Fasciitis Treatment Growth Rate (2017-2018)
Figure Canada Plantar Fasciitis Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Plantar Fasciitis Treatment Growth Rate (2017-2018)
Figure Mexico Plantar Fasciitis Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Plantar Fasciitis Treatment Growth Rate (2017-2018)
Figure Europe Plantar Fasciitis Treatment Revenue and Growth Rate (2017-2018)
Figure Europe Plantar Fasciitis Treatment by Countries (2017-2018)
Figure Europe Plantar Fasciitis Treatment Revenue (Million USD) by Countries (2017-2018)
Figure Germany Plantar Fasciitis Treatment Growth Rate (2017-2018)
Figure Germany Plantar Fasciitis Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Plantar Fasciitis Treatment Growth Rate (2017-2018)
Figure France Plantar Fasciitis Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Plantar Fasciitis Treatment Growth Rate (2017-2018)
Figure UK Plantar Fasciitis Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Plantar Fasciitis Treatment Growth Rate (2017-2018)
Figure Russia Plantar Fasciitis Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Plantar Fasciitis Treatment Growth Rate (2017-2018)
Figure Italy Plantar Fasciitis Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Plantar Fasciitis Treatment Growth Rate (2017-2018)
Figure Rest of Europe Plantar Fasciitis Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Plantar Fasciitis Treatment Growth Rate (2017-2018)
Figure Asia-Pacific Plantar Fasciitis Treatment Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Plantar Fasciitis Treatment by Countries (2017-2018)
Figure Asia-Pacific Plantar Fasciitis Treatment Revenue (Million USD) by Countries (2017-2018)
Figure China Plantar Fasciitis Treatment Growth Rate (2017-2018)
Figure China Plantar Fasciitis Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Plantar Fasciitis Treatment Growth Rate (2017-2018)
Figure Japan Plantar Fasciitis Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Plantar Fasciitis Treatment Growth Rate (2017-2018)
Figure Korea Plantar Fasciitis Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Plantar Fasciitis Treatment Growth Rate (2017-2018)
Figure India Plantar Fasciitis Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Plantar Fasciitis Treatment Growth Rate (2017-2018)
Figure Southeast Asia Plantar Fasciitis Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Plantar Fasciitis Treatment Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Plantar Fasciitis Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Plantar Fasciitis Treatment Growth Rate (2017-2018)
Figure South America Plantar Fasciitis Treatment Revenue and Growth Rate (2017-2018)
Figure South America Plantar Fasciitis Treatment by Countries (2017-2018)
Figure South America Plantar Fasciitis Treatment Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Plantar Fasciitis Treatment Growth Rate (2017-2018)
Figure Brazil Plantar Fasciitis Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Plantar Fasciitis Treatment Growth Rate (2017-2018)
Figure Argentina Plantar Fasciitis Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Plantar Fasciitis Treatment Growth Rate (2017-2018)
Figure Columbia Plantar Fasciitis Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Plantar Fasciitis Treatment Growth Rate (2017-2018)
Figure Rest of South America Plantar Fasciitis Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Plantar Fasciitis Treatment Growth Rate (2017-2018)
Figure Middle East and Africa Plantar Fasciitis Treatment Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Plantar Fasciitis Treatment by Countries (2017-2018)
Figure Middle East and Africa Plantar Fasciitis Treatment Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Plantar Fasciitis Treatment Growth Rate (2017-2018)
Figure Saudi Arabia Plantar Fasciitis Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Plantar Fasciitis Treatment Growth Rate (2017-2018)
Figure United Arab Emirates Plantar Fasciitis Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Plantar Fasciitis Treatment Growth Rate (2017-2018)
Figure Egypt Plantar Fasciitis Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Plantar Fasciitis Treatment Growth Rate (2017-2018)
Figure Nigeria Plantar Fasciitis Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Plantar Fasciitis Treatment Growth Rate (2017-2018)
Figure South Africa Plantar Fasciitis Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Plantar Fasciitis Treatment Growth Rate (2017-2018)
Figure Turkey Plantar Fasciitis Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Plantar Fasciitis Treatment Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Plantar Fasciitis Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Table GlaxoSmithKline plc Plantar Fasciitis Treatment Financial Overview
Table Sanofi Plantar Fasciitis Treatment Financial Overview
Table Pfizer, Inc. Plantar Fasciitis Treatment Financial Overview
Table Ottobock SE & Co. KGaA Plantar Fasciitis Treatment Financial Overview
Table Superfeet Worldwide, Inc. Plantar Fasciitis Treatment Financial Overview
Table Bauerfeind AG Plantar Fasciitis Treatment Financial Overview
Table A. Algeo Limited Plantar Fasciitis Treatment Financial Overview
Table Bayer Group Plantar Fasciitis Treatment Financial Overview
Table Hanger, Inc. Plantar Fasciitis Treatment Financial Overview
Figure Global Plantar Fasciitis Treatment Revenue (Millions USD) and Growth Rate (2018-2025)
Table Plantar Fasciitis Treatment Market Forecast by Regions (2018-2025)
Figure North America Plantar Fasciitis Treatment Market Forecast (2018-2025)
Figure United States Plantar Fasciitis Treatment Market Forecast (2018-2025)
Figure Canada Plantar Fasciitis Treatment Market Forecast (2018-2025)
Figure Mexico Plantar Fasciitis Treatment Market Forecast (2018-2025)
Figure Europe Plantar Fasciitis Treatment Market Forecast (2018-2025)
Figure Germany Plantar Fasciitis Treatment Market Forecast (2018-2025)
Figure France Plantar Fasciitis Treatment Market Forecast (2018-2025)
Figure UK Plantar Fasciitis Treatment Market Forecast (2018-2025)
Figure Russia Plantar Fasciitis Treatment Market Forecast (2018-2025)
Figure Italy Plantar Fasciitis Treatment Market Forecast (2018-2025)
Figure Rest of Europe Plantar Fasciitis Treatment Market Forecast (2018-2025)
Figure Asia-Pacific Plantar Fasciitis Treatment Market Forecast (2018-2025)
Figure China Plantar Fasciitis Treatment Market Forecast (2018-2025)
Figure Japan Plantar Fasciitis Treatment Market Forecast (2018-2025)
Figure Korea Plantar Fasciitis Treatment Market Forecast (2018-2025)
Figure India Plantar Fasciitis Treatment Market Forecast (2018-2025)
Figure Southeast Asia Plantar Fasciitis Treatment Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Plantar Fasciitis Treatment Market Forecast (2018-2025)
Figure South America Plantar Fasciitis Treatment Market Forecast (2018-2025)
Figure Brazil Plantar Fasciitis Treatment Market Forecast (2018-2025)
Figure Argentina Plantar Fasciitis Treatment Market Forecast (2018-2025)
Figure Columbia Plantar Fasciitis Treatment Market Forecast (2018-2025)
Figure Rest of South America Plantar Fasciitis Treatment Market Forecast (2018-2025)
Figure Middle East and Africa Plantar Fasciitis Treatment Market Forecast (2018-2025)
Figure Saudi Arabia Plantar Fasciitis Treatment Market Forecast (2018-2025)
Figure United Arab Emirates Plantar Fasciitis Treatment Market Forecast (2018-2025)
Figure Egypt Plantar Fasciitis Treatment Market Forecast (2018-2025)
Figure Nigeria Plantar Fasciitis Treatment Market Forecast (2018-2025)
Figure South Africa Plantar Fasciitis Treatment Market Forecast (2018-2025)
Figure Turkey Plantar Fasciitis Treatment Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Plantar Fasciitis Treatment Market Forecast (2018-2025)
Figure Global Plantar Fasciitis Treatment Forecast by Type (2018-2025)
Figure Global Plantar Fasciitis Treatment Market Share Forecast by Type (2018-2025)
Figure Global Plantar Fasciitis Treatment Forecast by Type (2018-2025)
Figure Global Plantar Fasciitis Treatment Forecast by End User (2018-2025)
Figure Global Plantar Fasciitis Treatment Market Share Forecast by End User (2018-2025)
Figure Global Plantar Fasciitis Treatment Forecast by End User (2018-2025)

Please Note: Data related to the Companies are subject to Availability.

Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources
  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources
  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)
  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

Request Sample Enquire Before Buying Request for Customization

Request Sample